Capvizr
THE DEAL, AT A GLANCE

Astrocyte Pharmaceuticals

From the announcement
01What happenedAstrocyte Pharmaceuticals raised $9.5M Series B, announced 2026-09-30From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersAstrocyte Pharmaceuticals' $9.5 Million Series B supports continued clinical advancement of AST-004, a therapy in Phase 2 clinical development for sports-related…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Astrocyte Pharmaceuticals · Financing Record

Explore source-linked visual explanations for Astrocyte Pharmaceuticals. Unsupported claims are withheld while source review continues.

Record 13084 · Recorded date: 2026-09-30

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime